Stockreport

BRIEF-FDA Approves Genentech's Tecentriq In Combination With Chemotherapy For Initial Treatment Of Adults With Extensive-Stage Small Cell Lung Cancer [Reuters]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF BRIEF-FDA Approves Genentech's Tecentriq In Combination With Chemotherapy For Initial Treatment Of Adults With Extensive-Stage Small Cell Lung Cancer | Reuters 1 Min Rea [Read more]